FR2924942B1 - Compositions pharmaceutiques transcutanees contenant une hormone steroidienne - Google Patents

Compositions pharmaceutiques transcutanees contenant une hormone steroidienne

Info

Publication number
FR2924942B1
FR2924942B1 FR0759864A FR0759864A FR2924942B1 FR 2924942 B1 FR2924942 B1 FR 2924942B1 FR 0759864 A FR0759864 A FR 0759864A FR 0759864 A FR0759864 A FR 0759864A FR 2924942 B1 FR2924942 B1 FR 2924942B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
compositions containing
steroidal hormone
containing steroidal
transcutaneous pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0759864A
Other languages
English (en)
Other versions
FR2924942A1 (fr
Inventor
Elie Leverd
Joel Bougaret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0759864A priority Critical patent/FR2924942B1/fr
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to AU2008337731A priority patent/AU2008337731A1/en
Priority to EP08862840A priority patent/EP2231115A1/fr
Priority to RU2010128471/15A priority patent/RU2010128471A/ru
Priority to KR1020107015043A priority patent/KR20100093589A/ko
Priority to US12/812,727 priority patent/US20100292199A1/en
Priority to CN200880125929XA priority patent/CN101932305A/zh
Priority to CA2711961A priority patent/CA2711961A1/fr
Priority to NZ586759A priority patent/NZ586759A/xx
Priority to PCT/EP2008/066808 priority patent/WO2009077345A1/fr
Publication of FR2924942A1 publication Critical patent/FR2924942A1/fr
Priority to ZA2010/04921A priority patent/ZA201004921B/en
Application granted granted Critical
Publication of FR2924942B1 publication Critical patent/FR2924942B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
    • G01S15/00—Systems using the reflection or reradiation of acoustic waves, e.g. sonar systems
    • G01S15/88—Sonar systems specially adapted for specific applications
    • G01S15/89—Sonar systems specially adapted for specific applications for mapping or imaging
    • G01S15/8906—Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques
    • G01S15/8909—Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques using a static transducer configuration
    • G01S15/8929—Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques using a static transducer configuration using a three-dimensional transducer configuration
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
    • G01S7/00—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00
    • G01S7/52—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00 of systems according to group G01S15/00
    • G01S7/52017—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00 of systems according to group G01S15/00 particularly adapted to short-range imaging
    • G01S7/52046—Techniques for image enhancement involving transmitter or receiver
    • G01S7/52047—Techniques for image enhancement involving transmitter or receiver for elimination of side lobes or of grating lobes; for increasing resolving power

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Remote Sensing (AREA)
  • Physics & Mathematics (AREA)
  • Radar, Positioning & Navigation (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acoustics & Sound (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • General Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0759864A 2007-12-14 2007-12-14 Compositions pharmaceutiques transcutanees contenant une hormone steroidienne Expired - Fee Related FR2924942B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR0759864A FR2924942B1 (fr) 2007-12-14 2007-12-14 Compositions pharmaceutiques transcutanees contenant une hormone steroidienne
NZ586759A NZ586759A (en) 2007-12-14 2008-12-04 Aqueous-alcoholic, single-phase transcutaneous pharmaceutical compositions containing a steroid hormone
RU2010128471/15A RU2010128471A (ru) 2007-12-14 2008-12-04 Фармацевтические композиции для чрескожного введения, содержащие стероидный гормон
KR1020107015043A KR20100093589A (ko) 2007-12-14 2008-12-04 스테로이드 호르몬을 함유하는 경피성 약학적 조성물
US12/812,727 US20100292199A1 (en) 2007-12-14 2008-12-04 Transcutaneous pharmaceutical compositions containing a steroid hormone
CN200880125929XA CN101932305A (zh) 2007-12-14 2008-12-04 含有甾体类激素的经皮药物组合物
AU2008337731A AU2008337731A1 (en) 2007-12-14 2008-12-04 Transcutaneous pharmaceutical compositions containing a steroid hormone
EP08862840A EP2231115A1 (fr) 2007-12-14 2008-12-04 Compositions pharmaceutiques transcutanees contenant une hormone steroidienne
PCT/EP2008/066808 WO2009077345A1 (fr) 2007-12-14 2008-12-04 Compositions pharmaceutiques transcutanees contenant une hormone steroidienne
CA2711961A CA2711961A1 (fr) 2007-12-14 2008-12-04 Compositions pharmaceutiques transcutanees contenant une hormone steroidienne
ZA2010/04921A ZA201004921B (en) 2007-12-14 2010-07-13 Transcutaneous pharmaceutical compositions containing a steroid hormone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0759864A FR2924942B1 (fr) 2007-12-14 2007-12-14 Compositions pharmaceutiques transcutanees contenant une hormone steroidienne

Publications (2)

Publication Number Publication Date
FR2924942A1 FR2924942A1 (fr) 2009-06-19
FR2924942B1 true FR2924942B1 (fr) 2012-06-15

Family

ID=39493869

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0759864A Expired - Fee Related FR2924942B1 (fr) 2007-12-14 2007-12-14 Compositions pharmaceutiques transcutanees contenant une hormone steroidienne

Country Status (11)

Country Link
US (1) US20100292199A1 (fr)
EP (1) EP2231115A1 (fr)
KR (1) KR20100093589A (fr)
CN (1) CN101932305A (fr)
AU (1) AU2008337731A1 (fr)
CA (1) CA2711961A1 (fr)
FR (1) FR2924942B1 (fr)
NZ (1) NZ586759A (fr)
RU (1) RU2010128471A (fr)
WO (1) WO2009077345A1 (fr)
ZA (1) ZA201004921B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE055562T2 (hu) 2011-11-23 2021-11-29 Therapeuticsmd Inc Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP3145489A1 (fr) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Formulations d'hormones substitutives combinées naturelles et traitement hormonal substitutif
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
BR112018070199A2 (pt) 2016-04-01 2019-01-29 Therapeuticsmd Inc composição farmacêutica de hormônio esteroide
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2019138356A1 (fr) 2018-01-11 2019-07-18 M et P Pharma AG Traitement de maladies démyélinisantes
WO2022055927A1 (fr) * 2020-09-11 2022-03-17 Ps Therapy Ltd. Compositions topiques et procédés d'utilisation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
JPH08501529A (ja) * 1992-06-11 1996-02-20 セラテック・インコーポレイテッド 皮膚透過薬剤投与緩和のグリセリン使用
AU1429697A (en) * 1995-12-29 1997-07-28 Cygnus, Inc. Systems and methods for the transdermal administration of androgenic agents
NZ335561A (en) * 1996-12-03 2001-05-25 Minnesota Mining & Mfg Transdermal/transmucosal patch dispenser with patches interconnected by patch of adhesive at alternative ends of patches, and dispensed through aperture in chamber
EP0979072B1 (fr) * 1997-02-28 2005-04-27 Minnesota Mining And Manufacturing Company Dispositif transdermique d'administration de testosterone
US6562369B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
DE10159120B4 (de) * 2001-12-01 2006-08-17 Lts Lohmann Therapie-Systeme Ag Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
US20030215487A1 (en) * 2002-05-17 2003-11-20 Il Yang Pharm Co., Ltd. Republic Of Korea Matrix-type device for the transdermal delivery of testosterone applied to the non-scrotal skin
US20050020552A1 (en) * 2003-07-16 2005-01-27 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050025833A1 (en) * 2003-07-16 2005-02-03 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20070048360A1 (en) * 2005-08-23 2007-03-01 R Carrara Dario N Pharmaceutical compositions with melting point depressant agents and method of making same

Also Published As

Publication number Publication date
EP2231115A1 (fr) 2010-09-29
US20100292199A1 (en) 2010-11-18
RU2010128471A (ru) 2012-01-20
CA2711961A1 (fr) 2009-06-25
AU2008337731A1 (en) 2009-06-25
KR20100093589A (ko) 2010-08-25
CN101932305A (zh) 2010-12-29
ZA201004921B (en) 2011-03-30
WO2009077345A1 (fr) 2009-06-25
NZ586759A (en) 2012-08-31
FR2924942A1 (fr) 2009-06-19

Similar Documents

Publication Publication Date Title
FR2924942B1 (fr) Compositions pharmaceutiques transcutanees contenant une hormone steroidienne
IL275854A (en) Pharmaceutical composition and its administration
LTPA2018005I1 (lt) Farmacinė kompozicija
HRP20181346T1 (hr) Transdermalni farmaceutski pripravci koji sadrže aktivne tvari
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
HK1164059A1 (en) Compositions for drug administration
EP2291157A4 (fr) Compositions et procédés d administration transdermique de composés pharmaceutiques
EP2045251A4 (fr) Composés inhibiteurs ubc13-uev, compositions pharmaceutiques et applications thérapeutiques
BRPI0721651A2 (pt) Composição farmacêutica
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0809661A2 (pt) Composição farmacêutica estabilizada contendo pregabalina
DK3300729T3 (da) Terapeutiske sammensætninger indeholdende macitentan
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI0820198A2 (pt) composições farmacêuticas
EP2320729A4 (fr) Composés de glycoside et compositions pharmaceutiques de ceux-ci
IL222707B (en) Steroid compounds of 16-chloro- and 16, 16-dichloro-(4-alpha, 4-beta)-17-beta-(2-oxo-2h-pyran-5-yl) and pharmaceutical preparations containing them
BRPI0912074A2 (pt) composto e composição farmacêutica
DK1886686T3 (da) Farmaceutisk sammensætning indeholdende mometasonfuroat
FR2945535B1 (fr) Compose anticancereux et composition pharmaceutique le contenant
ZA201101053B (en) Pharmaceutical compositions of samatotrophic hormones
DK2158908T3 (da) Sammensætning til transdermal administrering
EP2197454A4 (fr) Compositions pharmaceutiques pour l'administration d'oligonucléotides
BRPI0820839A2 (pt) Composição farmacêutica

Legal Events

Date Code Title Description
CJ Change in legal form
ST Notification of lapse

Effective date: 20130830